Skip to main content
SpringerLink
Log in

Quantitative Assays for Virus Infectivity

  • Chapter
Book cover Techniques in HIV Research

Abstract

The infectivity assay is used to titrate virus-containing clarified culture supernatant fluids to determine the 50%-tissue culture infective dose (TCID50) of HIV-1 per ml of original fluid. The ability to measure the amount of infectious virus present in virus-containing fluid is important and useful, particularly for determining the input multiplicity of infection for antiviral experiments [1]. It is a more sensitive and specific assay of virus infectivity than the determination of HIV-1 p24 antigen production or RT activity, as the latter values may also include the measurement of defective virions. This assay can be modified for use with different viral isolates and different cell types.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Hartshorn, K. L., Vogt, M. W., Chou, T.-C., Blumberg, R. S., Byington, R., Schooley, R. T., and Hirsch, M. S. 1987. Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon. Antimicrob Agents Chemother 31:168–172.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  2. Dulbecco, R. 1988. “End point Method — Measurement of the infectious titer of a viral sample” in the chapter entitled: The Nature of Viruses. In Virology, Second Edition, J. P. Lippincott, Philadelphia, pp. 22–25.

    Google Scholar 

References

  1. Mandel, B. 1979. Interaction of viruses with neutralizing antibodies. In Comprehensive Virology, Vol. 15, H. Fraenkel-Conrat, and R. R. Wagner, eds. Plenum Press, New York, pp. 37–121.

    Chapter  Google Scholar 

  2. Mandel, B. 1978. Neutralization of animals viruses. Adv Virus Res 23:205.

    Article  PubMed  CAS  Google Scholar 

  3. Dimmock, N. J. 1984. Mechanisms of neutralization of animal viruses. J Gen Virol 65:1015.

    Article  PubMed  Google Scholar 

  4. Dulbecco, R., Vogt, M., and Stickland, A. G. R. 1956. A study of the basic aspects of neutralization of two animals viruses, western equine encephalitis virus and poliomyelitis virus. Virology 2:162.

    Article  PubMed  CAS  Google Scholar 

  5. Wohlfart, C. 1988. Neutralization of adenoviruses. Stoichiometry and Mechanisms. J Virol 62:2321.

    PubMed  CAS  PubMed Central  Google Scholar 

  6. Nara, P. L., Hatch, W. C., Dunlop, N. M., Robey, W. G., Arthur, L. O., Gonda, M. A., and Fischinger, P. J. 1987. Simple, rapid, quantitative syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res Hum Retroviruses 3:283.

    Article  PubMed  CAS  Google Scholar 

  7. Nara, P. L., and Fischinger, P. J, 1988. Quantitative infectivity assay for HIV-1 and-2. Nature 332:469.

    Article  PubMed  CAS  Google Scholar 

  8. Nara, P. L. 1988. A binding/postbinding event mediated through the gp120 immunodominant epitope. In Retroviruses of Human AIDS and Related Animal Diseases, M. Girad, and L. Valette, eds. Pasteur Vaccines, Paris, pp. 138–150, Ref. ID #278.

    Google Scholar 

  9. Nara, P. L. 1989. HIV-1 neutralization: Evidence for rapid, binding/postbinding neutralization from infected humans, chimpanzees, and gp120-vaccinated animals. In Vaccines 89, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, pp. 137–144, Ref. ID #135.

    Google Scholar 

  10. Nara, P. L., Huang, K. M., Rausch, D. M., Lifson, J. D., and Eiden, L. E. 1989. CD4 antigen-based antireceptor peptides inhibit infectivity of human immunodeficiency virus in vitro at multiple stages of virus life cycle. Proc Natl Acad Sci USA 86:7139–7143.

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  11. Hosoi, S., Borsos, T., Dunlop, N., and Nara, P. L. 1990. Heat-labile, complement-like factor(s) of animal sera prevent(s) HIV-1 infectivity in vitro. JAIDS 3:366–371.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02114, USA

    Victoria A. Johnson & Roy E. Byington

  2. NCI Frederick Cancer Research Facility, Frederick, MD, 21701-1013, USA

    Peter L. Nara

Authors
  1. Victoria A. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Roy E. Byington
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter L. Nara
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Whitehead Institute, Cambridge, MA, USA

    Anna Aldovini

  2. Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA

    Bruce D. Walker

Copyright information

© 1990 Stockton Press

About this chapter

Cite this chapter

Johnson, V.A., Byington, R.E., Nara, P.L. (1990). Quantitative Assays for Virus Infectivity. In: Aldovini, A., Walker, B.D. (eds) Techniques in HIV Research. Palgrave Macmillan, London. https://doi.org/10.1007/978-1-349-11888-5_4

Download citation

  • DOI: https://doi.org/10.1007/978-1-349-11888-5_4

  • Publisher Name: Palgrave Macmillan, London

  • Print ISBN: 978-1-349-11890-8

  • Online ISBN: 978-1-349-11888-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation